Hongchang International Co., Ltd. (HCIL) intrinsic value & 10-year financials

Hongchang International Co., Ltd. (HCIL) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 1.1% a year to $2.9M, with an average return on invested capital of -190.7%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$0.01
Market cap
$3.0M
Revenue (FY2024)
$2.9M
Revenue growth (10-yr CAGR)
-1.1%
ROIC (10-yr avg)
-190.7%
Free cash flow (FY2024)
-$11.4M

HCIL 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2024 $2.9M -$472.4K $0.00 -$11.4M -13.4% -0.8%
FY2023 $2.7M -$378.8K $0.00 -$39.8M -17.5% -2.1%
FY2022 $79.0K -$265.6K $0.00 — -336.6% 15.7%
FY2021 $96.5K -$163.0K $0.00 — -168.8% 12.1%
FY2020 $222.7K -$548.4K — — -125.2% 55.3%
FY2019 $163.7K -$488.4K — — -328.8% 76.5%
FY2018 — -$247.8K — — — 170.1%
FY2017 — -$54.1K $0.00 — — 100.0%
FY2016 $188.2K -$158.5K $0.00 — -153.0% -100.0%
FY2015 $3.2M -$3.5M -$0.04 — -50.2% -2234.3%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Hongchang International Co., Ltd is facing top-line stagnation, with revenue contracting over the decade.

Hongchang International Co., Ltd returns on capital have been average, hovering around 13.6% ROIC over the decade.

Hongchang International Co., Ltd has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Hongchang International Co., Ltd is modeled at -1.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.00 per share.

HCIL stock: frequently asked questions

What is the intrinsic value of Hongchang International Co., Ltd. (HCIL) stock?

Graham's formula only works with positive earnings. Hongchang International Co., Ltd. reported diluted EPS of $0.00 in fiscal 2024, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

How fast has Hongchang International Co., Ltd. grown?

Revenue went from $3.2M in fiscal 2015 to $2.9M in fiscal 2024, a compound annual growth rate of -1.1%. Net income was -$472.4K in fiscal 2024.

Does Hongchang International Co., Ltd. generate free cash flow?

Hongchang International Co., Ltd. generated -$11.4M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2024. Free cash flow was positive in 0 of the last 2 reported years.

What is HCIL's return on invested capital?

Average ROIC over the last 10 fiscal years was -190.7%, and average return on equity was -188.6%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this HCIL data come from?

From Hongchang International Co., Ltd.'s annual 10-K filings on SEC EDGAR, most recently filed Feb 13, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar electromedical & electrotherapeutic apparatus stocks